While targeting TCF4-impacted genes presents a fundamental conceptual challenge as a therapeutic approach, directly overcoming the core genetic defect underlying PTHS may offer a more effective treatment strategy. Here, TCF4 is linked to Pitt-Hopkins syndrome.